ArticleFrontiers in genetics2025
Why all MODY variants in transcription factor genes are dominantly inherited.
Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Maturity-onset diabetes of the young (MODY) is an autosomal dominant form of monogenic diabetes, frequently caused by heterozygous loss-of-function variants in transcription factor (TF) genes. Why are MODY variants in TF genes dominantly inherited? Here I present a systems biology-based explanation. The fact that MODY-associated TFs are master regulators of pancreatic β cell fate suggests that pathogenic variants cause defects in cell fate determination. From a systems biology perspective, cell fate defects are based on disrupted bistability, a crucial feature of dynamical systems to make binary choices. Bistability requires both positive feedback and ultrasensitivity, the latter often in the form of cooperativity. MODY-associated TFs exhibit both features, which not only allows for bistability, but also makes these TFs extremely dosage sensitive, which explains why heterozygous loss of function is sufficient to cause a disease phenotype. A review of the literature strongly supports this hypothesis. Moreover, the hypothesis also helps to explain why incomplete penetrance is such a pervasive feature of MODY-associated variants in TF genes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.